Sign in
4

Changes in Ownership

Emergent BioSolutions Inc. Filed Acc 0001367644-21-000044

EVP, Chief Medical Officer acquired 5,883 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Smith Karen L. · EVP, Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2021-02-24 Grant or award : show line 1 in the form +2,942 9,252 D
2021-02-24 Grant or award : show line 2 in the form +2,941 12,193 D

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-02-24 Grant or award : show line 3 in the form Employee Stock Options (Right to Buy) +11,765 $93.49 $1,099,910 11,765 D
Loading xslF345X03/wf-form4_161437771751742.xml…